Exelixis Inc (NAS:EXEL)
$ 35.91 0.06 (0.17%) Market Cap: 10.26 Bil Enterprise Value: 9.24 Bil PE Ratio: 23.02 PB Ratio: 4.51 GF Score: 91/100

Exelixis Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 12:30AM GMT
Release Date Price: $23.27 (+3.24%)
Unidentified Analyst

Hi, everyone, and welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is [Natalie Collins], and I'm an associate on the JPMorgan Healthcare Investment Banking team.

Just a reminder, we'll follow 25 minutes of presentation time followed by 15 minutes of Q&A. And with that, I'm pleased to introduce the CEO of Exelixis, Michael Morrissey.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Thanks, Alex. All right. Well, good afternoon, everybody. Great to be here. Thanks for sticking around just in the first part of the game. All right. We're good to go. All right. Thank you. Small technical issue there. So again, good afternoon. Great to be here. Thanks for sticking around. Really enjoyed our first day here at JPMorgan. I want to thank Mike and Josh and Ben and the whole banking team. We had a great schedule, just packed one-on-ones today, starting at, I think, 8:15 until few minutes ago. So really high level of interest. We're excited to be here coming off strong 2023. JPMorgan is always a sprint for us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot